(Q34568691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Endogenous type I interferons as a defense against tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Ion Gresser

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

Cytokine and Growth Factor Reviews

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

111-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

A fresh look at tumor immunosurveillance and immunotherapy.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Tumors of the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Increased survival in mice inoculated with tumor cells and treated with interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

How does interferon inhibit tumour growth?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Isolation of interferon-resistant variants of friend erythroleukemia cells: Effects of interferon and ouabain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Purification of mouse interferon by sequential affinity chromatography on poly(U)– and antibody–agarose columns

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Current concepts: immunology. Transplantation immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Differential Behaviour of Transplanted Mouse Lymphoma Lines in Genetically Compatible Homozygous and F1 Hybrid Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Production and role of interferon in physiological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

The physiological interferon response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Antitumour effects of interferons: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Wherefore interferon?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Interferon inhibits the generation of allospecific suppressor T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Cellular Immunity Against Tumor Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Demonstration of Syngeneic Preference In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Enhanced NK cell activity in mice injected with interferon and interferon inducers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Role of interferons and other cytokines in the regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Interferon messenger RNA is produced constitutively in the organs of normal individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900035-1

7 January 2021

10.1016/S1359-6101(01)00035-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11900987%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference